Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 266,558 | 36,280 | 43,069 | 42,551 | 55,143 |
| Marketable Securities | 286,428 | 356,239 | 394,302 | 379,175 | 400,078 |
| TOTAL | $563,929 | $410,226 | $451,933 | $433,890 | $467,626 |
| Non-Current Assets | |||||
| PPE Net | 6,650 | 6,880 | 7,705 | 8,027 | 8,218 |
| Investments And Advances | 0 | 18,903 | 21,213 | 28,035 | 30,406 |
| Intangibles | 3,736 | 3,736 | 3,736 | 3,736 | 3,736 |
| Other Non-Current Assets | 47,129 | 49,597 | 54,723 | 55,505 | 57,870 |
| TOTAL | $57,515 | $79,116 | $87,377 | $95,303 | $100,230 |
| Total Assets | $621,444 | $489,342 | $539,310 | $529,193 | $567,856 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,305 | 12,818 | 11,247 | 9,820 | 12,041 |
| Accrued Expenses | 39,454 | 43,540 | 45,400 | 44,241 | 36,595 |
| TOTAL | $51,759 | $56,358 | $56,647 | $54,061 | $48,636 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 46,440 | 46,606 | 47,799 | 45,268 | 45,107 |
| TOTAL | $46,403 | $47,319 | $48,639 | $46,394 | $46,397 |
| Total Liabilities | $98,162 | $103,677 | $105,286 | $100,455 | $95,033 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,609 | 59,478 | 59,418 | 57,069 | 56,984 |
| Common Shares | 70 | 59 | 59 | 57 | 57 |
| Retained earnings | -772,111 | -659,584 | -596,365 | -541,394 | -486,993 |
| Other shareholders' equity | -197 | -378 | -1,132 | -2,036 | -1,446 |
| TOTAL | $523,282 | $385,665 | $434,024 | $428,738 | $472,823 |
| Total Liabilities And Equity | $621,444 | $489,342 | $539,310 | $529,193 | $567,856 |